HSA/MAU 尿微量白蛋白抗体

货号：RB913702129
价格：面议
点击：10991

产品介绍

尿微量蛋白的检测是早期发现肾病最敏感、最可靠的诊断指标。通过尿微量白蛋白的数值，结合发病情况、症状以及病史陈述就可以较为准确的诊断病情。

产品名称	类型	货号	来源	建议使用	应用
HSA抗原	Ag		human	质控	EIA、LF
HSA-1	mAb		mouse	包被	EIA、LF
HSA-2	mAb		mouse	标记	EIA、LF

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Human IL5 Recombinant Antibody , FITC\|抗人IL5重组抗体，FITC(靶标：人白细胞介素-5)	454
Anti-Human ALPP/PLAP Recombinant Antibody, FITC\|抗人ALPP/PLAP重组抗体，FITC(靶标：人胎盘碱性磷酸酶（PLAP）)	246
Anti-Human FGF1/aFGF Recombinant Antibody , FITC\|抗人FGF1/aFGF重组抗体，FITC(靶标：人成纤维细胞生长因子1（酸性FGF）)	450
Anti-Human IL6 Recombinant Antibody , FITC\|抗人IL6重组抗体，FITC(靶标：人白细胞介素-6)	492
Anti-Human CD54/ICAM1 Recombinant Antibody , FITC\|抗人CD54/ICAM1重组抗体，FITC(靶标：人CD54（ICAM-1）)	461
Anti-Human CD54/ICAM1 Recombinant Antibody , FITC\|抗人CD54/ICAM1重组抗体，FITC(靶标：人CD54（ICAM-1）)	457
Anti-Human CD29/ITGB1 Recombinant Antibody, FITC\|抗人CD29/ITGB1重组抗体，FITC(靶标：人CD29（整合素β1）)	465
Anti-Human CD29/ITGB1 Recombinant Antibody, FITC\|抗人CD29/ITGB1重组抗体，FITC(靶标：人CD29（整合素β1）)	245
Anti-Human CD1a Recombinant Antibody, FITC\|抗人CD1a重组抗体，FITC(靶标：人CD1a)	392
Anti-Human CD5 Recombinant Antibody, FITC\|抗人CD5重组抗体，FITC(靶标：人CD5)	161
Anti-Human CD5 Recombinant Antibody, FITC\|抗人CD5重组抗体，FITC(靶标：人CD5)	313
Anti-Human CD220/INSR Recombinant Antibody, FITC\|抗人CD220/INSR重组抗体，FITC(靶标：人CD220（胰岛素受体）)	529
Anti-Human CD220/INSR Recombinant Antibody , FITC\|抗人CD220/INSR重组抗体，FITC(靶标：人CD220（胰岛素受体）)	412
Anti-Human CD2 Recombinant Antibody, FITC\|抗人CD2重组抗体，FITC(靶标：人CD2)	212
Anti-Human CD2 Recombinant Antibody , FITC\|抗人CD2重组抗体，FITC(靶标：人CD2)	461
Anti-Rat CD2/LFA-2/OX-34 Recombinant Antibody, FITC\|抗大鼠CD2/LFA-2/OX-34重组抗体，FITC(靶标：大鼠CD2)	360
Anti-Human CD66e/CEA/CEACAM5 Recombinant Antibody , FITC\|抗人CD66e/CEA/CEACAM5重组抗体，FITC(靶标：人CD66e（CEACAM-5/CEA）)	233
Anti-Human CD66e/CEA/CEACAM5 Recombinant Antibody, FITC\|抗人CD66e/CEA/CEACAM5重组抗体，FITC(靶标：人CD66e（CEACAM-5/CEA）)	451
Anti-Human CD66e/CEA/CEACAM5 Recombinant Antibody, FITC\|抗人CD66e/CEA/CEACAM5重组抗体，FITC(靶标：人CD66e（CEACAM-5/CEA）)	541
Anti-Human CD23/FCER2 Recombinant Antibody, FITC\|抗人CD23/FCER2重组抗体，FITC(靶标：人CD23（FcεRII）)	294